Dil Afroze

Prof. Dil Afroze

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
BRBilal Rah
Bilal Rah
RRRafiq A Rather
Rafiq A Rather
GBGh Rasool Bhat
Gh Rasool Bhat
ABAbdul Basit Baba
Abdul Basit Baba
IMIfra Mushtaq
Ifra Mushtaq
DADil Afroze
Dil Afroze
JAK/STAT signaling pathway is one of the important regulatory signaling cascades for the myriad of cellular processes initiated by various types of ligands such as growth factors, hormones, and cytokines. The physiological processes regulated by JAK/STAT signaling are immune regulation, cell proliferation, cell survival, apoptosis and hematopoiesis of myeloid and non-myeloid cells. Dysregulation of JAK/STAT signaling is reported in various immunological disorders, hematological and other solid malignancies through various oncogenic activation mutations in receptors, downstream mediators, and associated transcriptional factors such as STATs. STATs typically have a dual role when explored in the context of cancer. While several members of the STAT family are involved in malignancies, however, a few members which include STAT3 and STAT5 are linked to tumor initiation and progression. Other STAT members such as STAT1 and STAT2 are pivotal for antitumor defense and maintenance of an effective and long-term immune response through evolutionarily conserved programs. The effects of JAK/STAT signaling and the persistent activation of STATs in tumor cell survival; proliferation and invasion have made the JAK/STAT pathway an ideal target for drug development and cancer therapy. Therefore, understanding the intricate JAK/STAT signaling in the pathogenesis of solid malignancies needs extensive research. A better understanding of the functionally redundant roles of JAKs and STATs may provide a rationale for improving existing cancer therapies which have deleterious effects on normal cells and to identifying novel targets for therapeutic intervention in solid malignancies.

29 December 2017 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
DADil Afroze
Dil Afroze
Ashok KumarAshok Kumar
Ashok Kumar

18 May 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
GBGh. Rasool Bhat
Gh. Rasool Bhat
ISItty Sethi
Itty Sethi
BRBilal Rah
Bilal Rah
RKRakesh Kumar
Rakesh Kumar
DADil Afroze
Dil Afroze
Bioinformatics is an amalgamation of biology, mathematics and computer science. It is a science which gathers the information from biology in terms of molecules and applies the informatic techniques to the gathered information for understanding and organizing the data in a useful manner. With the help of bioinformatics, the experimental data generated is stored in several databases available online like nucleotide database, protein databases, GENBANK and others. The data stored in these databases is used as reference for experimental evaluation and validation. Till now several online tools have been developed to analyze the genomic, transcriptomic, proteomics, epigenomics and metabolomics data. Some of them include Human Splicing Finder (HSF), Exonic Splicing Enhancer Mutation taster, and others. A number of SNPs are observed in the non-coding, intronic regions and play a role in the regulation of genes, which may or may not directly impose an effect on the protein expression. Many mutations are thought to influence the splicing mechanism by affecting the existing splice sites or creating a new sites. To predict the effect of mutation (SNP) on splicing mechanism/signal, HSF was developed. Thus, the tool is helpful in predicting the effect of mutations on splicing signals and can provide data even for better understanding of the intronic mutations that can be further validated experimentally. Additionally, rapid advancement in proteomics have steered researchers to organize the study of protein structure, function, relationships, and dynamics in space and time. Thus the effective integration of all of these technological interventions will eventually lead to steering up of next-generation systems biology, which will provide valuable biological insights in the field of research, diagnostic, therapeutic and development of personalized medicine.

26 September 2015 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
DADil Afroze
Dil Afroze
AYAdfar Yousuf
Adfar Yousuf
NTNisar A Tramboo
Nisar A Tramboo
ZSZaffar A. Shah
Zaffar A. Shah
AAAsrar Ahmad
Asrar Ahmad

1 January 2021
Verified
Closed access
KAKhaled S. Allemailem
Khaled S. Allemailem
AAAhmad Almatroudi
Ahmad Almatroudi
FAFaris Alrumaihi
Faris Alrumaihi
NANahlah Makki Almansour
Nahlah Makki Almansour
FAFahad M. Aldakheel
Fahad M. Aldakheel
BRBilal Rah
Bilal Rah

25 January 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
IJIqra Jan
Iqra Jan
RRRafiq A. Rather
Rafiq A. Rather
IMIfra Mushtaq
Ifra Mushtaq
AMAjaz A. Malik
Ajaz A. Malik
SBSyed Besina
Syed Besina
DADil Afroze
Dil Afroze
Helicobacter pylori infection has been associated with the onset of gastric mucosal inflammation and is known to perturb the balance between T-regulatory (Treg) and T-helper 17 (Th17) cells which causes a spurt of interleukin 17 (IL17) and transforming growth factor-β (TGF-β) from Th17 and Treg cells within the gastric milieu. IL17 instigates a surge of interleukin 6 (IL6) from T-helper 1 (Th1) and T-helper 2 (Th2) cells. Further, H. pylori infection is known to stimulate the atypical DNA methylation in gastric mucosa. However, the precise role of cytokine signaling in induction of epigenetic modifications during gastric carcinogenesis is vaguely understood. In this study, patient samples from were examined using real-time polymerase chain reaction (qPCR), PCR, methylation-specific (MS)-PCR, and enzyme-linked immunosorbent assays. We found that H. pylori infection augments the production of interleukin 10 (IL10), IL6, and TGF-β in the gastric milieu and systemic circulation. Together with the IL6/IL10 mediated hyperactivation of the JAK/STAT pathway, H. pylori infection causes the inactivation of suppressor of cytokine signaling 1 (SOCS1) gene through the hypermethylation of the promoter region. This study signifies that H. pylori-mediated epigenetic silencing of SOCS1 in concert with inflammatory cytokines miffs hyperactivation of the JAK/STAT cascade during gastric carcinogenesis.